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The emergence of pathogenic bacteria with β-lactam antibiotics-resistant profile has 
threatened the continued use of such antibiotics in the future. This research was conducted to 
investigate the antimicrobial activity of green tea ethanol extract (GTE) and its ability to improve 
the antibacterial action of several β-lactam antibiotics against Enterobacter cloacae clinical 
isolates. The simplicia of green tea was extracted by sonication for 30 minutes using 50% ethanol 
solvent, and the total phenolic content of the GTE was subsequently determined. Next, the GTE 
used in testing against two clinical isolates of E. cloacae was obtained from the Pathology 
Laboratory of  Wahidin Sudiro Husodo Hospital in Makassar. The sensitivity of bacteria to GTE 
was confirmed using the agar diffusion method, the Vitek® rapid method, and the double-disk 
synergistic test. Antibacterial activity of antibiotics, GTE, and combination of antibiotics with GTE 
were then tested against clinical isolates of E. cloacae using the checkerboard microdilution assay. 
The results showed that GTE contained 51.64 ± 0.21 % measured as gallic acid equivalent and 
37.95 + 5.17 % Epigallocatechin gallate (EGCG). The confirmatory test results indicated that one 
clinical isolate of E. cloacae (code 13/04) was resistant to amoxicillin-clavulanate but did not 
produce an extended-spectrum β-lactamase (ESBL). Another clinical E. cloacae isolate (code 
275B/06) was indicated to produce ESBL and demonstrated to yield resistance to amoxicillin-
clavulanate and cefotaxime. The minimum inhibitory concentration of GTE against the two clinical 
isolates of E. cloacae was >8000 ppm (8 mg/ml). In conclusion, GTE could not increase the 
antibacterial activity of amoxicillin and cefotaxime, but it was sufficient to improve the activity of 
imipenem against the tested isolates of E. cloacae. 
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In the last decade, many Enterobacter cloacae complex (ECC) that were initially classified 
as opportunistic have been regarded as infectious-causing bacteria in hospitals and turned out to be 
resistant to conventional or even newer generations of antibiotics (Annavajhala et al., 2019). 
Enterobacter cloacae, one of the Enterobacteriaceae species, is frequently isolated from patient 
specimens taken from the blood and the respiratory-, urinary-, and digestive tracts (Mezzatesta et 
al., 2012; Davin-Regli and Pagès, 2015). In addition, this pathogen has also been reported to 
contaminate medical equipment in hospitals (Davin-Regli and Pagès, 2015). Clinical isolates of E. 
cloacae were previously reported to be resistant against carbapenem, tigecycline, colistin (Huang et 
al., 2017). It was found that out of 385 patient specimens, 64.68% were found to be positive for 
pathogenic bacteria, including E. cloacae (2%). Unfortunately, third-generation cephalosporins 
were also inefficient against most of these bacteria (Radji et al., 2011). 
Researchers are trying to find appropriate solutions in response to the increased cases of 
infection by antibiotic-resistant bacteria, the scarcity of effective antibiotics, and the high cost 
required to discover new antibiotics (Towse et al., 2017). One of the suggested ways is by 
maintaining the use of existing antibiotics in combination with bioactive compounds from 
medicinal plants that could further improve the antibacterial activity of those antibiotics (Coutinho 
et al., 2008; Matias et al., 2011). It has been recently reported that certain phenolic compounds can 
increase the antibacterial activity of conventional antibiotics (Sartini et al., 2019). For example, the 
MICs of kanamycin, gentamycin, amikacin, neomycin were decreased as much as 87.5% or even 
99.9% when they were used in combination with the flavonoid-rich ethanolic extract of Croton 
campestris leaves (Júnior et al., 2011). 
One of the natural resources demonstrated to incite antimicrobial activity against some 
pathogenic bacteria is green tea (Sartini et al., 2019). The antibacterial properties of green tea are 
mainly attributed to the catechin and caffeine compounds (Scoparo et al., 2012; Bermejo et al., 
2015). In fact, epigallocatechin gallate (EGCG), a major catechin present in the green tea, was 
reported to increase gentamycin activity against multi-drug resistant (MDR) Escherichia coli 
(Parvez et al., 2019). However, it is essential to note that the combination of caffeine with several 
antibiotics yielded no improvement or even antagonistic activity towards some pathogenic bacteria 
(Bazzaz et al., 2016). Therefore, it is essential to note that the clinical combination of certain 
bioactive plant compounds and the existing antibiotics does not always improve the corresponding 
antibiotics' antibacterial activity. This research was carried out aiming to investigate whether green 
tea extract (GTE) could yield antibacterial activity and/or to improve the antibacterial activity of 
several β-lactam antibiotics (amoxicillin, cefotaxime, and imipenem) against clinical isolates of E. 
cloacae. Once it is proven, the use of existing β-lactam antibiotics can be further explored, in 
combination with certain bioactive compounds or plant extracts, for the clinical management of 
antibiotic-resistant pathogenic bacteria. 
  
MATERIALS AND METHOD  
Materials 
Green tea used in this study was one of the commercial products marketed in Makassar, 
South Sulawesi, Indonesia. All antibiotic preparations and gallic acid were procured from Sigma-
Aldrich. The Vitek®2 AST-G07 cassette (bioMe'rieux, Durham, NC), Brain Heart Infusion Broth 
(Merck), Muller Hinton Agar (Merck), and clinical isolates of E. cloacae were obtained from the 
Clinical Pathology Laboratory of Wahidin Sudiro Husodo Hospital in Makassar. 
 
Preparation of green tea ethanol extract 
Green tea ethanolic extract, or referred to as green tea extract (GTE), was prepared based on 
the previously established method (Sartini et al., 2019) with slight modifications. Briefly, GTE was 
prepared by firstly extracting the coarse powder of green tea by ultrasound-assisted maceration 
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method for 15 minutes using hexane (1:10) to eliminate non-polar compounds. The resulting 
extract was subsequently subjected to ultra-sonication-assisted maceration using 50 % ethanol with 
ratio of 1:10 for 15 minutes, and the resulting liquid GTE was kept at room temperature for 1×24 
hours. At the designated time, the liquid GTE was processed using rotary evaporator at 60 °C and 
freeze dried to eliminate the water residue. 
 
Calculation of total phenolic content and epigallocatechin gallate content 
Total phenolic content (TPC) was confirmed and calculated by Folin–Ciocalteu 
spectrophotometry method based on the established protocol (Sartini et al., 2020), with slight 
modifications. Briefly, 10 mg of GTE was dissolved in methanol to obtain GTE concentrations of 
600, 300, 150, and 75 µg/mL, respectively. Afterward, 100 µL of the obtained solution was 
immediately added to 2.5 mL of 7.5% w/v Folin-Ciocalteu reagent and homogenized. Following 
this step, 2.4 mL of 1% w/v NaOH was subsequently added to the mixture. The reaction was 
maintained at ambient temperature for 60 minutes, and the resulting absorbance was determined 
using UV spectrophotometer -1800 (Shimadzu). Gallic acid was used as the standard solution. 
Next, the amount of epigallocatechin gallate (EGCG) in the GTE was determined using 
Ultra-Fast Liquid Chromatography (UFLC). Initially, serial dilutions of standard EGCG were 
prepared in methanol to obtain a calibration curve with concentrations ranged from 3.25 μg/mL to 
200 μg/mL. Afterward, 10 mg of GTE was dissolved in methanol, and the resulting solution was 
injected into the UFLC to precisely quantify the EGCG concentration. 
 
Antibiotic susceptibility test 
Susceptibilities of clinical isolates of E. cloacae (codes 13/04 and 275B/06) to antibiotics 
were tested using both Vitek®2 automatic test and disk diffusion methods (Stone et al., 2007), with 
slight modifications. For the Vitek®2 automatic test, bacterial suspension was freshly prepared in 
0.45% saline to achieve equal turbidity with 0.5 McFarland standard of the Densi-Chek 2 system 
(bioMe'rieux, Durham, NC). Subsequently, an antibacterial susceptibility testing card (AST-GN07) 
was inoculated with the prepared bacterial suspension. Results obtained from Vitek®2 were 
interpreted categorically based on the Advanced Expert System when available. For disk diffusion 
assay, plates of sterile Mueller-Hinton Agar were inoculated with 10 μL of bacterial suspension, by 
spread methods, equal to the turbidity of 0.5 McFarland standard. Commercially available 
antibiotic disks were immediately placed on the Mueller-Hinton Agar and incubated at 37°C for 
1×24 hours. Interpretations of disk diffusion tests were carried out for Enterobacteriaceae based on 
the CLSI guidance, and categorical interpretations (susceptible, intermediate, or resistant) were 
subsequently assigned. The production of extended-spectrum β-lactamases (ESBL) was 
investigated by the double-disc synergy test (DDST) method, using cefotaxime and ceftazidime, 
either alone or in combination with clavulanic acid according to the previous study (Khalaf et al., 
2008). 
 
Determination of antibacterial and modulation assay of green tea extract (GTE) 
  The MIC of GTE, amoxicillin, cefotaxime, imipenem, and their combination was carried 
out by using the checkerboard microdilution assay (Fankam et al., 2017; Parvez et al., 2019), with 
slight modifications. Briefly, two-fold serial dilutions of each sample were freshly prepared in the 
BHIB in 96-well microtiter plates. Then, the suspension of E. cloacae was inoculated to each well 
to achieve 106 CFU/mL of final concentration. Sequentially, the microplates were incubated at 
37°C for 1×24 hours, and the MIC was subsequently determined by adding 10 μL solution of 0.1 % 
triphenyl tetrazolium chloride (TTC) to each well prior to incubation at ambient temperature for 30 
minutes. The lowest concentration of the tested samples with unobservable TTC reduction to red 
formazan after a 30-minute incubation at 37°C was defined as the MIC value. In addition, the 
modulation factor of the GTE was calculated based on the ratio of the MIC for the antibiotic alone 
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and the MIC of the antibiotics in the presence of GTE. Modulation factor ≥ 2 was used as the cut-
off value to indicate substantial effects of the corresponding sample(s) in the reduction of the 
antibiotic resistance profiles of the tested pathogens (Fankam et al., 2017). 
 
RESULTS AND DISCUSSION  
Extraction yield, total phenolic, and EGCG contents 
Extraction processes used in this research were carried out based on the method described in 
established publications (Veillet et al., 2010; Sartini et al., 2020). A summary of extraction yield, 
TPC, and EGCG content calculated from the obtained GTE are shown in Table 1. 
Table 1.  Extraction yield (%), total phenolic content (TPC), and EGCG content of green tea 
ethanolic extract 
Extraction Yield (%) TPC (%) EGCG (%) 
27.87 51.64 + 0.21 37.95 + 5.17 
As shown in Table 1, TPC obtained in this study was approximately doubled compared to 
the previous study results (Sartini et al., 2019). In addition, we also found that the GTE prepared in 
this study contained higher EGCG than our previous result (Sartini et al., 2019). While the true 
nature of such discrepancy remains unknown, we hypothesized that the high content of polyphenols 
in the extract obtained in this study is due to an additional pre-treatment in the extraction process. 
As described in the method section, we performed GTE extraction using hexane with ultrasound-
assisted extraction (UAE) to remove the non-polar components from GTE prior to the final 
extraction procedure using 50% ethanol. The mechanical effect of UAE accelerated the release of 
organic compounds that contained within the plant body by disrupting cell walls, enhancing mass 
transfer, and facilitating solvent access to the cell content (Pasrija and Anandharamakrishnan, 
2015).  
 
Susceptibility profiles of E. cloacae clinical isolates to β-lactam antibiotics 
Susceptibility profiles of E. cloacae clinical isolates were determined using disk diffusion 
(Table 2), Vitek®2 (Table 3), and DDST (Figure 1 and Table 4) methods. Based on the results 
obtained from the agar disk diffusion test (Table 1) and Vitek®2 rapid test (Table 2), it appears that 
the clinical isolates of E.cloacae code 13/04 were resistant to the penicillin derivative (amoxicillin-
clavulanate) and sensitive to other antibiotics used in the assay: the cephalosporins (cefotaxime, 
ceftazidime, ceftriaxone) and the carbapenems (imipenem, meropenem, doripenem). However, the 
susceptibility profile of E. cloacae clinical isolate code 275B/06 was quite different from the 13/04. 
While the 275B/06 E. cloacae were still sensitive to the carbapenems (imipenem, meropenem, and 
doripenem), this clinical isolate appeared to be resistant to the penicillin derivative (amoxicillin-
clavulanate) and the cephalosphorins (cefotaxime, ceftazidime, cefazoline, cefoxitin). Our results 
suggest that the two clinical isolates of E. cloacae might have different profiles in the availability 
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Table 2.  Susceptibility patterns of E. cloacae clinical isolates to β-lactam antibiotics by disk 
diffusion method 
E. cloacae  
isolates 
Inhibition zone diameter (mm)  
Penicillin Cephalosporines Carbapenems 
AMC CAZ CRO CTX IMI MEM 
13/04 8   R 31   S 33 S 34  S 29  S 27  S 
275B/06 8   R 17   R   8 R   8  R 27  S 25  S 
Note: AMC: amoxicillin-clavulanate (20/10 μg); CAZ: ceftazidime (30 μg); CTX: cefotaxime (30 μg); CRO: 
cefriaxone (30 μg); IMI: imipenem (10 μg); MEM: meropenem (10 μg);   S: sensitive, I: intermediate, R: 
resistant 
 
Table 3.  Susceptibility patterns of E. cloacae clinical isolates to β-lactam antibiotics by 
Vitek®2 rapid test method 
Note: AMC: amoxicillin-clavulanate; CAZ: ceftazidime; CTX: cefotaxim; CRO: ceftriaxone; IMI: 
imipenem; MEM: meropenem; DORI: doripenem; S: sensitive, I: intermediate, R: resistant 
 
Further analysis using the DDST method revealed that the 276B/06 isolate was an extended-
spectrum β-lactamase (ESBL) E. cloacae, while the 13/04 isolate was not (Figure 1 and Table 4). 
This is because the inhibitory zone diameter of cefotaxime-clavulanate was more than 5 mm 
compared to the result shown by cefotaxime alone. Since many bacteria in the Gram-negative 
Enterobacteriaceae family have been shown to be ESBL-producers (Rodríguez-Baño et al., 2018), 
our DDST result was already anticipated. Moreover, the same report (Rodríguez-Baño et al., 2018) 
suggested that the profile of clinically resistant E. cloacae was achieved not only by producing 
ESBL alone but may also involve the production of AmpC β-lactamase. This remains an interesting 




Figure 1. Susceptibility profiles of E. cloacae clinical isolates to cefotaxime, ceftazidime, cefotaxime-
clavulanate, and ceftazidime-clavulanate by DDST method. A. E. cloacae code 13/04 (ESBL 





E. cloacae  
isolates 
Antibiotics MIC (ppm) determined by Vitek-2 rapid test assay 
Penicillin             Cephalosporines  Carbapenem  
AMC CAZ CTX CRO IMI MEM DORI 
13/04 > 32 R < 1  S < 1  S < 1  S < 0.25 S < 0.25  S <  0.12 S 
275B/06 ˃ 32 R ˃ 64  R ˃ 64 R  > 64  R 0.5 S < 0.25  S <  0.12 S 
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Table 4.  Inhibition zone diameter (mm) of several antibiotics against E. cloacae clinical 
isolates  








13/04 26 25 28 28 ESBL Negative 
275B/06 24 12 24 8 ESBL Positive 
Note: ESBL: extended-spectrum β-lactamase 
 
 
Minimum inhibitory concentration of β-Lactam antibiotics and/or GTE against E. cloacae 
clinical isolates 
To determine the antibacterial activity of β-lactam antibiotics or GTE in a single form or 
combination, we performed a checkerboard broth microdilution assay. This method has been 
suggested as one of the proper methods in determining the synergetic effect of two antibacterial or 
antibiotics used in combination (Jain et al., 2011; El-Azizi, 2016). As shown in Figure 2 and Table 
5, the MIC of GTE against both E. cloacae clinical isolates (13/04 and 275B/06) were higher than 
8,000 ppm, suggesting that the antibacterial activity of GTE is ineffective to both β-lactam-
sensitive (13/04) and β-lactam-resistant (275B/06) E. cloacae. In other words, the absence of GTE 
antibacterial activity observed in this study was not due to the resistance profile of E. cloacae. The 
reason for such results remains to be determined in the future.  
             A                                            B                                               C 
Figure 2.  Checkerboard broth microdilution assay for antibiotics and/or GTE against E. cloacae 
clinical isolates 
 Notes: The sample test using two-fold dilution. A. Amoxicillin (2000 - 2 ppm); B. Cefotaxime (8000  – 8 
ppm);  C. Imipenem (250 – 0,25 ppm).  
Antibiotics (Row A1-A11); GTE (column 1/ B1-F1); Antibiotic + GTE combination (Row B2-G11). Row H 
(control media + bacteria; control media); Column 12 (control media + GTE).  
Red color in the media denotes bacterial growth, yellow color in the media indicates no bacterial growth 
 
 
Table 5.  Minimum inhibitory concentration (MICs) of amoxicillin, cefotaxime, imipenem, 
green tea extract (GTE), and combination of antibiotics with sub-inhibitory GTE 
against E. cloacae clinical isolates 
Test Samples 
MIC (ppm) 
E. cloacae   13/04 E. cloacae 275B/06 
Amoxicillin > 2, 000 > 2, 000 
Cefotaxime 125  > 8,000 
Imipenem 7.5 15 
GTE > 8,000 > 8,000 
Amoxicillin + sub inhibitory GTE >2,000 >2,000 
Cefotaxime + sub inhibitory GTE 125 > 8,000 
Imipenem + sub inhibitory GTE 0.2 7.5 
  Note: concentration of sub-inhibitory GTE used in the assay was 8,000 ppm 
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Figure 2 (B1 – F1) and Table 5 show that the ethanolic extract of green tea up to a 
concentration of 8% (8000 ppm) has not shown antibacterial activity against E.cloacae, which 
means that GTE is not effective as an antibacterial against  E.cloacae. In the previous report, GTE 
was reported to constrain Escherichia coli with MIC value < 4000 ppm (Reygaert, 2014). We 
previously reported that GTE could impede Staphylococcus aureus growth at a concentration of 
300 ppm (Sartini et al., 2019).  This is in line with the notion that the antimicrobial properties of 
green tea catechins are effective, to a greater extent, to Gram-positive bacteria than the Gram-
negative ones (Reygaert, 2014). EGCG, the major catechin of green tea, has been considered a 
promising component in the GTE responsible for GTE's broad antibacterial activity against some 
Gram-negative and Gram-positive bacteria. This catechin can inhibit bacterial growth by several 
mechanisms, i.e., inhibition of bacterial cell wall synthesis, impairment of fatty acid synthesis, and 
inhibition of important enzymatic activities (Nakayama et al., 2013; Reygaert, 2014; Miklasińska et 
al., 2016). 
From Table 5, it can be seen that the combination of antibiotics with GTE did not change 
the MIC values of amoxicillin and cefotaxime on the clinical isolates of E. cloacae tested in this 
study, suggesting that GTE did not augment the antibacterial activity of the corresponding 
antibiotics. However, it is essential to note that the antibacterial activities of imipenem against the 
non-ESBL E. cloacae (code 13/04) and the ESBL strain of E. cloacae (code 275B/06) were 
increased by forty-fold and two-fold, respectively. Our results were in line with the previous 
research results that demonstrated the enhanced bactericidal activity of imipenem against imipenem 




Green tea ethanolic extract (GTE) was able to augment the antibacterial activity of imipenem 
against both the non-ESBL and the ESBL isolates of E. cloacae. However, it did not provide any 
beneficial effect on the antibacterial activities of amoxicillin and cefotaxime.  
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